Psychosis Following an Increase in Intrathecal Baclofen

Mithra B. Maneyapanda, Sangeeta Patel Driver, David L. Ripley, Robert Lloyd, Nenad Brkic*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Baclofen is a commonly used medication to treat spasticity in neurologic disorders. In the traumatic brain injury (TBI) population, the intrathecal administration of baclofen is often preferred over oral administration due to cognitive side effects. Here we report on a case of a psychotic episode following an increase in intrathecal baclofen in a young man with a history of a TBI. Although intrathecal baclofen is commonly used and is generally well tolerated, this case highlights an important potential effect of intrathecal baclofen that has rarely been reported in the literature. Level of Evidence V

Original languageEnglish (US)
Pages (from-to)1222-1224
Number of pages3
JournalPM and R
Volume8
Issue number12
DOIs
StatePublished - Dec 1 2016

ASJC Scopus subject areas

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation
  • Neurology
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Psychosis Following an Increase in Intrathecal Baclofen'. Together they form a unique fingerprint.

Cite this